» Articles » PMID: 34858137

A Standardized Brain Molecular Atlas: A Resource for Systems Modeling and Simulation

Overview
Specialty Molecular Biology
Date 2021 Dec 3
PMID 34858137
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Accurate molecular concentrations are essential for reliable analyses of biochemical networks and the creation of predictive models for molecular and systems biology, yet protein and metabolite concentrations used in such models are often poorly constrained or irreproducible. Challenges of using data from different sources include conflicts in nomenclature and units, as well as discrepancies in experimental procedures, data processing and implementation of the model. To obtain a consistent estimate of protein and metabolite levels, we integrated and normalized data from a large variety of sources to calculate Adjusted Molecular Concentrations. We found a high degree of reproducibility and consistency of many molecular species across brain regions and cell types, consistent with tight homeostatic regulation. We demonstrated the value of this normalization with differential protein expression analyses related to neurodegenerative diseases, brain regions and cell types. We also used the results in proof-of-concept simulations of brain energy metabolism. The standardized Brain Molecular Atlas overcomes the obstacles of missing or inconsistent data to support systems biology research and is provided as a resource for biomolecular modeling.

Citing Articles

Intraneuronal binding of amyloid beta with reelin-Implications for the onset of Alzheimer's disease.

Kobro-Flatmoen A, Omholt S PLoS Comput Biol. 2025; 21(1):e1012709.

PMID: 39775030 PMC: 11741591. DOI: 10.1371/journal.pcbi.1012709.


Brain energy metabolism: A roadmap for future research.

Rae C, Baur J, Borges K, Dienel G, Diaz-Garcia C, Douglass S J Neurochem. 2024; 168(5):910-954.

PMID: 38183680 PMC: 11102343. DOI: 10.1111/jnc.16032.


Digital Brain Maps and Virtual Neuroscience: An Emerging Role for Light-Sheet Fluorescence Microscopy in Drug Development.

Perens J, Hecksher-Sorensen J Front Neurosci. 2022; 16:866884.

PMID: 35516798 PMC: 9067159. DOI: 10.3389/fnins.2022.866884.

References
1.
Fecher C, Trovo L, Muller S, Snaidero N, Wettmarshausen J, Heink S . Cell-type-specific profiling of brain mitochondria reveals functional and molecular diversity. Nat Neurosci. 2019; 22(10):1731-1742. DOI: 10.1038/s41593-019-0479-z. View

2.
Ohse S, Boerries M, Busch H . Blind normalization of public high-throughput databases. PeerJ Comput Sci. 2021; 5:e231. PMC: 7924423. DOI: 10.7717/peerj-cs.231. View

3.
Kim S, Chen J, Cheng T, Gindulyte A, He J, He S . PubChem 2019 update: improved access to chemical data. Nucleic Acids Res. 2018; 47(D1):D1102-D1109. PMC: 6324075. DOI: 10.1093/nar/gky1033. View

4.
Barros L, San Martin A, Ruminot I, Sandoval P, Fernandez-Moncada I, Baeza-Lehnert F . Near-critical GLUT1 and Neurodegeneration. J Neurosci Res. 2017; 95(11):2267-2274. DOI: 10.1002/jnr.23998. View

5.
Hosp F, Gutierrez-Angel S, Schaefer M, Cox J, Meissner F, Hipp M . Spatiotemporal Proteomic Profiling of Huntington's Disease Inclusions Reveals Widespread Loss of Protein Function. Cell Rep. 2017; 21(8):2291-2303. PMC: 5714591. DOI: 10.1016/j.celrep.2017.10.097. View